Slow patient uptake of Pfizer’s Covid drug hints at end to sales boom
Paxlovid dominates antiviral treatment market but weak demand could cause supply glut, health data group Airfinity says
Paxlovid dominates antiviral treatment market but weak demand could cause supply glut, health data group Airfinity says